Neonatal outcomes of extremely preterm twins by sex pairing: an international cohort study.


Journal

Archives of disease in childhood. Fetal and neonatal edition
ISSN: 1468-2052
Titre abrégé: Arch Dis Child Fetal Neonatal Ed
Pays: England
ID NLM: 9501297

Informations de publication

Date de publication:
Jan 2021
Historique:
received: 15 01 2020
revised: 09 04 2020
accepted: 23 04 2020
pubmed: 27 5 2020
medline: 5 1 2021
entrez: 27 5 2020
Statut: ppublish

Résumé

Infant boys have worse outcomes than girls. In twins, the 'male disadvantage' has been reported to extend to female co-twins via a 'masculinising' effect. We studied the association between sex pairing and neonatal outcomes in extremely preterm twins. Retrospective cohort study SETTING: Eleven countries participating in the International Network for Evaluating Outcomes of Neonates. Liveborn twins admitted at 23-29 weeks' gestation in 2007-2015. We examined in-hospital mortality, grades 3/4 intraventricular haemorrhage or cystic periventricular leukomalacia (IVH/PVL), bronchopulmonary dysplasia (BPD), retinopathy of prematurity requiring treatment and a composite outcome (mortality or any of the outcomes above). Among 20 924 twins, 38% were from male-male pairs, 32% were from female-female pairs and 30% were sex discordant. We had no information on chorionicity. Girls with a male co-twin had lower odds of mortality, IVH/PVL and the composite outcome than girl-girl pairs (reference group): adjusted OR (aOR) (95% CI) 0.79 (0.68 to 0.92), 0.83 (0.72 to 0.96) and 0.88 (0.79 to 0.98), respectively. Boys with a female co-twin also had lower odds of mortality: aOR 0.86 (0.74 to 0.99). Boys from male-male pairs had highest odds of BPD and composite outcome: aOR 1.38 (1.24 to 1.52) and 1.27 (1.16 to 1.39), respectively. Sex-related disparities in outcomes exist in extremely preterm twins, with girls having lower risks than boys and opposite-sex pairs having lower risks than same-sex pairs. Our results may help clinicians in assessing risk in this large segment of extremely preterm infants.

Identifiants

pubmed: 32451356
pii: archdischild-2020-318832
doi: 10.1136/archdischild-2020-318832
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

17-24

Subventions

Organisme : Medical Research Council
ID : MR/T016752/1
Pays : United Kingdom
Organisme : Department of Health
ID : RP-PG-0707-10010
Pays : United Kingdom

Informations de copyright

© Author(s) (or their employer(s)) 2021. No commercial re-use. See rights and permissions. Published by BMJ.

Déclaration de conflit d'intérêts

Competing interests: None declared.

Auteurs

Luigi Gagliardi (L)

Division of Neonatology and Pediatrics, Ospedale Versilia, Viareggio, Azienda USL Toscana Nord Ovest, Italy l.gagliardi@neonatalnet.org.

Franca Rusconi (F)

Unit of Epidemiology, Anna Meyer Children's University Hospital and Regional Health Agency, Florence, Italy.

Brian Reichman (B)

Gertner Institute for Epidemiology and Health Policy Research, Sheba Medical Center, Tel Hashomer, Israel.

Mark Adams (M)

Department of Neonatology, University Hospital Zurich and University of Zurich, Zurich, Switzerland.

Neena Modi (N)

UK Neonatal Collaborative, Neonatal Data Analysis Unit, Section of Neonatal Medicine, Department of Medicine, Imperial College London, London, UK.

Liisa Lehtonen (L)

Department of Pediatrics and Adolescent Medicine, Turku University Hospital and Department of Clinical Medicine, University of Turku0, Turku, Finland.

Satoshi Kusuda (S)

Neonatal Research Network Japan, Maternal and Perinatal Center, Tokyo Women's Medical University, Tokyo, Japan.

Maximo Vento (M)

Division of Neonatology, Health Research Institute La Fe, Valencia, Spain.

Brian A Darlow (BA)

Department of Paediatrics, University of Otago Christchurch, Canterbury, New Zealand.

Dirk Bassler (D)

Department of Neonatology, University Hospital Zurich and University of Zurich, Zurich, Switzerland.

Tetsuya Isayama (T)

Division of Neonatology, National Center for Child Health and Development, Tokyo, Japan.

Mikael Norman (M)

Department of Neonatal Medicine, Karolinska University Hospital, Stockholm, Sweden.
Department of Clinical Science, Intervention and Technology, Karolinska Institutet, Stockholm, Sweden.

Stellan Håkansson (S)

Department of Clinical Science/Pediatrics, Umea University, Umea, Sweden.

Shoo K Lee (SK)

Department of Pediatrics, Mount Sinai Hospital, Toronto, Ontario, Canada.
Department of Pediatrics, University of Toronto, Toronto, Ontario, Canada.
Maternal-infant Care Research Centre, Mount Sinai Hospital, Toronto, Ontario, Canada.

Kei Lui (K)

Royal Hospital for Women, National Perinatal Epidemiology and Statistic Unit, 0, Randwick, New South Wales, Australia.

Junmin Yang (J)

Maternal-infant Care Research Centre, Mount Sinai Hospital, Toronto, Ontario, Canada.

Prakeshkumar Shah (P)

Department of Pediatrics, Mount Sinai Hospital, Toronto, Ontario, Canada.
Department of Pediatrics, University of Toronto, Toronto, Ontario, Canada.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH